Skip to main content
Livermore
Livermore
ZHEN

Evoke Wealth, LLC

SEC CIK
0001793432
Latest filing
Aug 10, 2026

NVO holding history

Novo Nordisk A S in every 13F filed by Evoke Wealth, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overviewAll 13F holders of NVOFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of NVO by Evoke Wealth, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−8,838−100.0%Sold outHolders
Q1 20268,838$335.3K<0.1%−718−7.5%ReducedHolders
Q4 20259,556$486.2K<0.1%−2,533−21.0%ReducedHolders
Q3 202512,089$670.8K<0.1%+4,221+53.6%AddedHolders
Q2 20257,868$543.1K<0.1%+2,404+44.0%AddedHolders
Q1 20255,464$385.7K<0.1%+198+3.8%AddedHolders
Q4 20245,266$453.0K<0.1%+19+0.4%AddedHolders
Q3 20245,247$624.8K<0.1%+5,247NewHolders
Q2 20240$00.0%−4,517−100.0%Sold outHolders
Q1 20244,517$584.2K<0.1%+4,517NewHolders
Q4 20230$00.0%−3,053−100.0%Sold outHolders
Q3 20233,053$277.6K<0.1%+279+10.1%AddedConverted for a 2-for-1 splitHolders
Q2 20231,387$224.5K<0.1%−17−1.2%ReducedHolders
Q1 20231,404$225.1K<0.1%+1,404NewHolders
Q4 20220$00.0%−655−100.0%Sold outHolders
Q3 2022655$65.0K<0.1%−146−18.2%ReducedHolders
Q2 2022801$89.0K<0.1%+1+0.1%AddedHolders
Q1 2022800$90.0K<0.1%−59−6.9%ReducedHolders
Q4 2021859$96.0K<0.1%00.0%UnchangedHolders
Q3 2021859$82.0K<0.1%+145+20.3%AddedHolders
Q2 2021714$60.0K<0.1%00.0%UnchangedHolders
Q1 2021714$49.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.